Savyon Diagnostics Ltd. of Ashdod at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Savyon Diagnostics Ltd.

3 Habosem Street, 7761003 Ashdod
Israel
Telephone +972 8 8562920
Fax +972 8 8523176
info@savyondiagnostics.com

Hall map

MEDICA 2019 hall map (Hall 3): stand F09

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.01  Bacteriology testing

Our products

Product category: Bacteriology testing

NanoCHIP Gastroenteritis

The NanoCHIP® GIP (Gastrointestinal Panels)  assays performed on the NanoCHIP® platform, is an automated qualitative in vitro diagnostic test for the direct detection and differentiation of human diarrheal bacteria and parasites in stool specimens from symptomatic patients.

Infectious gastroenteritis is one of the most common diseases worldwide. Estimation has been made in which about 3.5 billion people are affected, and that 450 million are ill as a result of these infections, the majority being children. Transmission of intestinal parasites and enteropathogenic bacteria is characterized as fecal-oral human-to-human transmission.

Diarrhea diseases are widely common in developed as well as developing countries and are major causes of morbidity and mortality, affecting millions of individuals each year. The etiologies of diarrhea include viruses (e.g., Norwalk-like viruses, rotaviruses, and enteric adenoviruses), bacteria (e.g., Campylobacter, Shigella, Salmonella, and cytotoxigenic Clostridium difficile), and parasites (e.g., Entamoeba histolytica, Giardia lamblia, Dientamoeba fragilis, Blastocystis hominis and Cryptosporidium spp.).

More Less

Product category: Bacteriology testing

NanoCHIP ZIKV/DENV/CHIKV

Zika, dengue, and Chikungunya virus are common in tropical regions. These viruses are spread and transmitted to people primarily through the bite of an infected Aedes species mosquito. Upon infection, common symptoms include, arthralgia, myalgia and conjunctivitis. As both the transmission vector and clinical symptoms are similar, it is crucial to differentiate between Zika, dengue, and Chikungunya at an early stage.

Zika virus, is a RNA flavivirus transmitted through daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. The name originates from the Zika Forest in Uganda, where the virus was first isolated in 1947. The infection, known as Zika fever, often causes none or only mild symptoms and is treated by rest. However Zika fever in pregnant women can cause abnormal brain development of the fetuses by mother to child transmission which may result in miscarriage or microcephaly. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. In 2014, the virus spread eastward across the Pacific Ocean to French Polynesia than to Ester Island and in 2015 to Mexico, Central America, the Caribbean, and South America, where the Zika outbreak has reached pandemic levels. The illness cannot yet be prevented by drugs or vaccines.

Dengue virus, is a RNA flavivirus transmitted through daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. Symptoms typically begin three to fourteen days after infection. This may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash. Recovery generally takes less than two to seven days. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs. The virus has four different types; infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications. Dengue has become a global problem since the Second World War and is common in more than 110 countries. Each year between 50 and 528 million people are infected and approximately 20,000 die.

Chikungunya virus, is an RNA virus related to the alphavirus genus, and Togaviridae family. The virus is passed to humans through daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. The disease features the sudden onset of fever two to four days after exposure. The fever usually lasts two to seven days, while accompanying joint pains typically last weeks or months but sometimes years. The mortality rate is a little less than 1 in 1000, with the elderly or those with underlying chronic medical problems most likely having severe complications. Animal reservoirs of the virus include monkeys, birds, cattle, and rodents. This is in contrast to Dengue, for which primates are the only hosts. Since 2004, the disease has occurred in outbreaks in Asia, Europe and the Americas

The NanoCHIP® ZIKV/DENV/CHIKV panel performed on the NanoCHIP® system, is an automated qualitative in vitro diagnostic test as an aid to the evaluation of infections with zika, dengue (I-IV) and chikungunya viruses in human serum and plasma.

More Less

Product category: Bacteriology testing

CoproStrip™ C. difficile GDH+Toxin A+Toxin B

The CoproStrip™ C. difficile GDH + Toxin A + Toxin B is a  rapid chromatographic immunoassay combo card for the simultaneous qualitative detection of Clostridium difficile Glutamate Dehydrogenase (GDH), Toxin A and Toxin B in human faeces that aids in the diagnosis of C.difficile infection.

The gram-positive anaerobic bacillus Clostridium difficile is the leading causative agent of antibiotic-associated diarrhea and pseudomembranous colitis. This pathogen is capable of causing disease that could be severe or fatal if not diagnosed on time and treated. Exposure to antibiotics is the major risk factor for C. difficile infection. Infection can develop if the normal gastrointestinal flora is disrupted by antibiotic therapy and a person acquires toxin-producing C. difficile, typically via the fecal-oral route. C. difficile’s key virulence factors are toxin A and toxin B. These toxins show high sequence and functional homology. Toxin A has been described as a tissue damaging enterotoxin which attracts neutrophils and monocytes and toxin B as a potent cytotoxin that degrades the colonic epithelial cells. Most virulent strains produce both toxins, however, toxin A negative/toxin B positive strains are also capable of causing disease. All strains of C. difficile produce high levels of GDH. Therefore, C. difficile’s GDH enzyme is considered a very good antigen marker for detection of this organism. The CoproStrip™C. difficile is a qualitative immunoassay for detection of Clostridium difficile Glutamate Dehydrogenase (GDH), Toxin A and Toxin B in human fecal specimens.

CoproStrip C. difficile test features:
  • Results obtained within 10 min
  • Simultaneous detection of both the C. difficile antigen, Toxin A and Toxin B (3 in one)
  • User friendly with minimal hands-on time. Only 1 min. of set-up
  • Toxin A and Toxin B differentiation
  • Compatible to the guidelines recommendation of GDH screening in combination with toxin testing to improve sensitivity.

More Less

Product category: Bacteriology testing

QuickStripe™ Chlamydia Ag

The QuickStripe™ Chlamydia Ag is a rapid chromatographic immunoassay for the qualitative detection of Chlamydia trachomatis in female cervical swab, male urethral swab and male urine specimens to aid in the diagnosis of Chlamydia infection

Chlamydia trachomatis is the most common cause of sexually transmitted venereal infection in the world. It is composed of elementary bodies (the infectious form) and reticulate or inclusions bodies (the replicating form). Chlamydia trachomatis has both a high prevalence and asymptomatic carriage rate, with frequent serious complications in both women and neonates. Complications of Chlamydia infection in women include cervicitis, urethritis, endometritis, pelvic inflammatory disease (PID) and increased incidence of ectopic pregnancy and infertility. Vertical transmission of the disease during parturition from mother to neonate can result in inclusion conjunctivitis pneumonia. In men, complications of Chlamydia infection include urethritis and epididymitis. At least 40% of the nongonococcal urethritis cases are associated with Chlamydia infection. Approximately 70% of women with endocervical infections and up to 50% of men with urethral infections are asymptomatic. Traditionally, Chlamydia infection has been diagnosed by detection of Chlamydia inclusions in tissue culture cells. Culture method is the most sensitive and specific laboratory method, but it is labor intensive, expensive, long (48-72 hours) and not routinely available in most institutions.

The QuickStripe Chlamydia Ag is a rapid test to qualitatively detect the Chlamydia antigen from female cervical swab, male urethral swab and male urine specimens, providing results in 10 minutes. The test utilizes antibody specific for Chlamydia to selectively detect Chlamydia antigen from female cervical swab, male urethral swab and male urine specimens.

More Less

Product category: Bacteriology testing

SeroFIA

The SeroFIA™ Chlamydia product line consists of IgG, IgM and IgA specific immunofluorescent assays (MIF) for the determination of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in human serum.

 

The user-friendly SeroFIA™ Chlamydia slides contain, for each of the three Chlamydia species, one row of seven antigen-coated wells which makes species identification convenient and rapid.

The performance of the SeroFIA™ Chlamydia is in excellent agreement with both commercial and in house conventional MIF test results. End point titer control is included to be used as a reference tool

SeroFIA™ Chlamydia kits contain 15 slides, each with 7 wells per specie. The SeroFIA™ slides can be custom made and contain antigens for one chlamydia specie only.

More Less

Product category: Bacteriology testing

QuickStripe™ Strep A

The QuickStripeTM Strep A is a rapid chromatographic immunoassay for the qualitative detection of Strep A antigen from throat swab specimens to aid in the diagnosis of Group A Streptococcal infection.

Streptococcus pyogenes is non-motile gram-positive cocci, which contains the Lancefield group A antigen that can cause serious infections such as pharyngitis, respiratory infection, impetigo, endocarditis, meningitis, puerperal sepsis, and arthritis. Left untreated, these infections can lead to serious complications, including rheumatic fever and peritonsillar abscess. Traditional identification procedures for Group A Streptococci infection involve the isolation and identification of viable organisms using techniques that require 24 to 48 hours or longer.

The QuickStripe Strep A is a rapid test to qualitatively detect the presence of Strep A antigen in throat swab specimens, providing results within 5 minutes. The test utilizes antibodies specific for whole cell Lancefield Group A Streptococcus to selectively detect Strep A antigen in a throat swab specimen.

More Less